神州细胞-U
(688520)
| 流通市值：177.29亿 | | | 总市值：177.29亿 |
| 流通股本：4.45亿 | | | 总股本：4.45亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,936,981,204.36 | 1,304,669,628.08 | 612,503,357.24 | 1,887,349,306.4 |
| 营业收入 | 1,936,981,204.36 | 1,304,669,628.08 | 612,503,357.24 | 1,887,349,306.4 |
| 二、营业总成本 | 1,459,232,956.3 | 951,441,163.69 | 454,129,612.34 | 1,909,716,643.41 |
| 营业成本 | 72,000,768.66 | 44,556,380.32 | 20,486,151.6 | 54,541,484.53 |
| 税金及附加 | 12,295,912.61 | 8,394,847.92 | 4,041,783.18 | 12,938,168.68 |
| 销售费用 | 490,550,392.62 | 307,579,548.25 | 124,602,499.38 | 436,150,158.25 |
| 管理费用 | 133,987,574.59 | 80,446,915.21 | 36,999,229.94 | 149,685,773.4 |
| 研发费用 | 671,785,468.55 | 460,041,347.92 | 237,334,271.65 | 1,148,170,339.03 |
| 财务费用 | 78,612,839.27 | 50,422,124.07 | 30,665,676.59 | 108,230,719.52 |
| 其中:利息费用 | 80,169,834.7 | 51,615,029.1 | 30,773,972.47 | 111,521,100.09 |
| 其中:利息收入 | 3,197,921.27 | 2,431,450.13 | 1,261,222.39 | 7,035,097.25 |
| 加:公允价值变动收益 | 26,027 | - | - | - |
| 加:投资收益 | 1,055,410.97 | 413,915.12 | 19,561.18 | 2,476,410.84 |
| 资产处置收益 | 3,194.48 | 16,088.83 | 9,016.38 | -64,332.7 |
| 资产减值损失(新) | -2,806,523.68 | -1,240,838.45 | -390,996.73 | -42,320,772.83 |
| 信用减值损失(新) | -2,139,025.12 | -1,612,874.15 | -561,976.09 | -1,021,990.84 |
| 其他收益 | 56,244,851.44 | 51,945,522.58 | 43,760,047.94 | 69,663,626.51 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 530,132,183.15 | 402,750,278.32 | 201,209,397.58 | 6,365,603.97 |
| 加:营业外收入 | 213,371.9 | 198,793.84 | 177,609.44 | 1,186,589.59 |
| 减:营业外支出 | 379,933,136.42 | 276,875,800.09 | 126,978,045.85 | 404,383,281.36 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 150,412,418.63 | 126,073,272.07 | 74,408,961.17 | -396,831,087.8 |
| 六、净利润 | 150,412,418.63 | 126,073,272.07 | 74,408,961.17 | -396,831,087.8 |
| 持续经营净利润 | 150,412,418.63 | 126,073,272.07 | 74,408,961.17 | -396,831,087.8 |
| 归属于母公司股东的净利润 | 149,954,058.54 | 125,705,731.32 | 74,197,374.04 | -396,018,311.08 |
| 少数股东损益 | 458,360.09 | 367,540.75 | 211,587.13 | -812,776.72 |
| (一)基本每股收益 | 0.34 | 0.28 | 0.17 | -0.89 |
| (二)稀释每股收益 | 0.34 | 0.28 | 0.17 | -0.89 |
| 八、其他综合收益 | 30,840.04 | 18,297.73 | -17,305.69 | -29,194.12 |
| 归属于母公司股东的其他综合收益 | 30,762.94 | 18,251.99 | -17,262.43 | -29,121.13 |
| 九、综合收益总额 | 150,443,258.67 | 126,091,569.8 | 74,391,655.48 | -396,860,281.92 |
| 归属于母公司股东的综合收益总额 | 149,984,821.48 | 125,723,983.31 | 74,180,111.61 | -396,047,432.21 |
| 归属于少数股东的综合收益总额 | 458,437.19 | 367,586.49 | 211,543.87 | -812,849.71 |
| 公告日期 | 2024-10-29 | 2024-08-22 | 2024-04-26 | 2024-04-13 |
| 审计意见(境内) | | | | 标准无保留意见 |